Citation: B. Schummer et al., SEMIQUANTITATIVE EVALUATION OF MRP GENE-EXPRESSION IN PROSTATE CARCINOMAS - RELATION TO HORMONE-THERAPY AND HISTOLOGY, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 494-494
Citation: M. Greschner et al., GENETIC-BASIS OF HEREDITARY UROLOGICAL DI SEASES .2. MALIGNANT DISEASES AND SYNDROMES, Aktuelle Urologie, 28(1), 1997, pp. 4-23
Citation: Ku. Kohrmann et al., OPERABILITY AND PROGNOSIS IN ADVANCED BLA DDER-CANCER FOLLOWING PRIMARY CHEMOTHERAPY - THE NEOADJUVANT CONCEPT, Onkologie, 19(1), 1996, pp. 87-89
Citation: A. Weber et al., NEOADJUVANT ANDROGEN DEPRIVATION PRIOR TO RADICAL PROSTATECTOMY - A TOOL IN SUCCESSFUL SURGICAL-TREATMENT OF CANCER OF THE PROSTRATE, Onkologie, 19(1), 1996, pp. 89-91
Authors:
NICHTERLEIN T
SIEGSMUND M
KRETSCHMAR M
HOF H
Citation: T. Nichterlein et al., ERYTHROMYCIN IS INEFFECTIVE AGAINST LISTERIA-MONOCYTOGENES IN MULTIDRUG-RESISTANT CELLS, Journal of chemotherapy, 7(3), 1995, pp. 184-188
Authors:
SEEMANN O
MUSCHECK M
SIEGSMUND M
PILCH H
NEBE CT
RASSWEILER J
ALKEN P
Citation: O. Seemann et al., ESTABLISHMENT AND CHARACTERIZATION OF A MULTIDRUG-RESISTANT HUMAN BLADDER-CARCINOMA CELL-LINE RT112 D21/, Urological research, 22(6), 1995, pp. 353-360